Jonathan D. Licht, MD
Director, The University of Florida Health Cancer Center
The Marshall E. Rinker, Sr. Foundation and
David B. and Leighan R. Rinker Chair
Jonathan D. Licht, MD, is the Director of the University of Florida Health Cancer Center, holding the Marshall E. Rinker, Sr. Foundation and David B. and Leighan R. Rinker Chair. Dr. Licht’s laboratory studies aberrant gene regulation, specifically the role of abnormal function of histone methyl transferases and histone demethylases in diseases such as multiple myeloma and is developing small molecule strategies to normalize gene regulation and treat disease.
NCI funded for nearly 30 years, Dr. Licht is also Principal Investigator of a Leukemia and Lymphoma Society Specialized Center and a Multiple Myeloma Research Foundation program grant both in epigenetics. He is an investigator in the Dana-Farber SPORE in myeloma and co-leader in a NCI-funded Chicago Region Physical Sciences Oncology Center. For 10 years Dr. Licht served as Senior Editor of Clinical Cancer Research and is currently an Associate Editor of Oncogene and serves on the editorial boards of Cancer Cell, Cancer Research and Clinical Cancer Research. Dr. Licht is a past councilor of of the American Society of Hematology, and co-led the 2017 ASH/EHA Translational Research Training program. He currently serves as chair of the Taskforce for Hematological Malignancies of the American Association for Cancer Research, serves on the Medical/Scientific Board of the a Leukemia and Lymphoma Society and is chair of the NIH Mechanisms of Cancer Therpeutics-1 Study Section. Dr. Licht has published nearly 190 original articles, reviews and book chapters. Dr. Licht has mentored over 40 graduate students and postdoctoral fellows and 20 faculty members.